Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study.
Opasich C, Boccanelli A, Cafiero M, Cirrincione V, Sindaco DD, Lenarda AD, Luzio SD, Faggiano P, Frigerio M, Lucci D, Porcu M, Pulignano G, Scherillo M, Tavazzi L, Maggioni AP; BRING-UP 2 Investigators. Opasich C, et al. Among authors: faggiano p. Eur J Heart Fail. 2006 Oct;8(6):649-57. doi: 10.1016/j.ejheart.2005.11.005. Epub 2006 Feb 8. Eur J Heart Fail. 2006. PMID: 16466962 Free article.
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study.
Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M; DYDA Investigators. Giorda CB, et al. Among authors: faggiano p. Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):415-23. doi: 10.1177/1741826710389402. Epub 2011 Feb 22. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 21450640
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, Maggioni AP, Masson S, Mureddu GF, Tarantini L, Velussi M, Comaschi M; DYDA Investigators. Cioffi G, et al. Among authors: faggiano p. Eur J Prev Cardiol. 2012 Oct;19(5):935-43. doi: 10.1177/1741826711417759. Epub 2011 Jul 28. Eur J Prev Cardiol. 2012. PMID: 21798988
Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?
Oliva S, Cioffi G, Frattini S, Simoncini EL, Faggiano P, Boccardi L, Pulignano G, Fioretti AM, Giotta F, Lestuzzi C, Maurea N, Sabatini S, Tarantini L; Italian Cardio-Oncological Network. Oliva S, et al. Among authors: faggiano p. Oncologist. 2012;17(7):917-24. doi: 10.1634/theoncologist.2011-0445. Epub 2012 Jun 6. Oncologist. 2012. PMID: 22673631 Free PMC article.
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis.
Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G; ICARO (Italian CARdio-Oncologic) Network. Tarantini L, et al. Among authors: faggiano p. Ann Oncol. 2012 Dec;23(12):3058-3063. doi: 10.1093/annonc/mds127. Epub 2012 Jun 13. Ann Oncol. 2012. PMID: 22700991 Free article.
339 results